Companies: 10,795·Total market cap: $144.5T
Akanda Corp.

Akanda Corp.

AKANNASDAQHealthcare● Active
$14.65
$-0.98(-6.27%)
Market Cap$474162
P/E Ratio
52W High$209.23424
52W Low$2.2973
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Akanda Corp. (AKAN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001888014 · AKAN · NASDAQ · as of Jun 10, 2026

Filing snapshot

189
Total Filings
20-F
Latest Form
2026-06-09
Most Recent
2022
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001888014 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-06-09
Fiscal Year End
Jun 9, 2026
Accession No.
0001213900-26-066800
Primary Document
ea0288681-20f_akanda.htm
Source: data.sec.gov · CIK 0001888014 · Accession 0001213900-26-066800

Latest Key Filings

6-KQuarterly Report
CURRENT REPORT
2026-05-22
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
20-FAnnual Report (Foreign Issuer)
ANNUAL REPORT
2026-06-09
View
6-KCurrent Report (Foreign Issuer)
CURRENT REPORT
2026-05-22
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-13
View
NT 20-FNT 20-F
NOTIFICATION OF LATE FILING
2026-05-01
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-29
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-10
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-09
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-07
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-02
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-31
View
F-1/AF-1/A
AMENDMENT NO. 3 TO FORM F-1
2026-03-20
View
F-1/AF-1/A
AMENDMENT NO. 2 TO FORM F-1
2026-03-04
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN ISSUER
2026-02-27
View
F-1/AF-1/A
AMENDMENT NO. 1 TO FORM F-1
2026-01-28
View
F-1F-1
REGISTRATION STATEMENT
2026-01-26
View
Showing 1–15 of 186 filingsForm 4 / 144 hidden· 189 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001888014  |  Exchange: NASDAQ · Healthcare

Akanda Corp. (NASDAQ: AKAN) has submitted 189 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2022. As a Healthcare sector company with CIK 0001888014, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Akanda Corp.'s most comprehensive regulatory disclosure. The most recent Akanda Corp. 10-K was filed on 2026-06-09 for fiscal year ending 2026. Historical AKAN 10-K annual reports are available from 2021 through 2026.

Investors researching Akanda Corp. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10

Frequently Asked Questions

AKAN SEC Filings · 8 questions

Akanda Corp. (AKAN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 189 filings and access original documents at no cost. Akanda Corp.'s CIK is 0001888014.

AKAN SEC filingsAkanda Corp. SEC documentsfind AKAN 10-K